HGC GesundheitsConsult GmbH, Mörsenbroicher Weg 200, 40470 Duesseldorf, Germany.
Robert-Bosch-Krankenhaus, Zentrum für Innere Medizin III Kardiologie, Auerbachstraße 110, 70376 Stuttgart, Germany.
J Comp Eff Res. 2019 Jun;8(8):589-597. doi: 10.2217/cer-2018-0114. Epub 2019 May 17.
This study evaluated the occurrence and associated costs of pacemaker complications in Germany from 2010 to 2013. Patients with a or replacement implantation of a single or dual chamber pacemaker between 2010 and 2013 were followed for 12 months post-implant using German health insurance claims data. A case-control analysis was performed using propensity score matching to estimate the costs of complications. Out of 12,922 implanted patients, 12.0% had a complication in the year following the implant. Complications related to lead and pocket were found in 10.2% of all implanted patients; infections occurred in 1.7% patients. Healthcare costs up to 36 months post complication were on average €4627 higher than for pacemaker patients without a complication. Pacemaker complications are common and represent a burden for patients and healthcare systems generating substantial costs. Most of the pacemaker complications involved the pacing lead or pacemaker pocket.
这项研究评估了 2010 年至 2013 年德国起搏器并发症的发生情况及其相关成本。使用德国健康保险索赔数据，对 2010 年至 2013 年间植入单腔或双腔起搏器的患者进行了 12 个月的随访。采用倾向评分匹配进行病例对照分析，以估算并发症的成本。在 12922 名植入患者中，有 12.0%在植入后的一年中出现并发症。所有植入患者中有 10.2%与导联和囊袋相关的并发症；1.7%的患者发生感染。与无并发症的起搏器患者相比，并发症发生后 36 个月内的医疗保健费用平均高出 4627 欧元。起搏器并发症很常见，给患者和医疗系统带来了负担，产生了大量成本。大多数起搏器并发症涉及起搏导联或起搏器囊袋。
